The use of the anti-tumour necrosis factor monoclonal antibody--infliximab--to treat ulcerative colitis: implications and trends beyond the available data.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Maurizio Fadda Mario Rizzetto |
| Publication date | June 1, 2004 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |